Skip to content

Medical-device intelligence

LSK: Dna-Reagents, Chlamydia

FDA product code LSK: Dna-Reagents, Chlamydia. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LSK
FDA device name
Dna-Reagents, Chlamydia
Device class
1
Regulation number
866.3120
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

8 clearance records and 1 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Oct 28, 1987 to Dec 20, 2010.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LSK · Dna-Reagents, Chlamydia81

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
Abbott RealTime CT/NG Assay, List 8L07, in vitro diagnostic; Abbott Molecular Inc., Des Plaines, IL 60018 USA The Abbott RealTime CT/NG assay is …Z-1397-2011 · LSKAbbott MolecularRecallFeb 23, 2011FDA classification date
ABBOTT REALTIME CT/NG AND ABBOTT MULTI-COLLECT SPECIMEN COLLECTION KIT, MODELS 8L07-91, 9K12-03K092704 · LSKAbbott Molecular, Inc.510(k)May 28, 2010FDA decision date
MODIFICATION TO HYBRID CAPTURE II CT/GC TEST, MODEL 03M90-01K010891 · LSKDigene Corp.510(k)Sep 25, 2001FDA decision date
MODIFICATION HYBRID CAPTURE II CT-ID DNA TEST, MODEL 03M91-01K010892 · LSKDigene Corp.510(k)Sep 24, 2001FDA decision date
HYBRID CAPTURE II CT-ID TESTK990023 · LSKDigene Corp.510(k)Oct 25, 1999FDA decision date
PACE 2 CHLAMYDIA TRACHOMATIS PROBE CONFIRM ASSAYK920302 · LSKGen-Probe, Inc.510(k)Apr 6, 1994FDA decision date
PACE 2 SYSTEM FOR CHLAMYDIA TRACHOMATISK920378 · LSKGen-Probe, Inc.510(k)Apr 29, 1992FDA decision date
GEN-PROBE(R) PACE(TM) SYSTEM CHLAMYDIA TRACHOMATISK874878 · LSKGen-Probe, Inc.510(k)Dec 29, 1987FDA decision date
RAPID DIAGNOSTIC SYSTEM FOR CHLAMYDIA TRACHOMATISK871878 · LSKGen-Probe, Inc.510(k)Oct 28, 1987FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗